Header cover image

Media Healthcare Sector

Results

2308

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2,308 companies

Belluscura

Market Cap: UK£3.8m

Develops and commercialize oxygen related medical device products in the United States.

BELL

UK£0.0095

7D

-7.3%

1Y

-94.3%

CordovaCann

Market Cap: US$5.1m

Engages in identifying, funding, developing, and managing operations in the cannabis value chain business.

LVRL.F

US$0.046

7D

-34.3%

1Y

-37.4%

CompuMed

Market Cap: US$5.0m

An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.

CMPD

US$3.80

7D

26.2%

1Y

123.5%

IM Cannabis

Market Cap: CA$7.0m

Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.

IMCC

CA$2.27

7D

-3.4%

1Y

-60.2%

Palatin Technologies

Market Cap: US$5.0m

A biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States.

0KF3

US$0.15

7D

38.2%

1Y

-92.6%

CanadaBis Capital

Market Cap: CA$6.9m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

CANB

CA$0.05

7D

0%

1Y

-44.4%

BioElectronics

Market Cap: US$4.9m

An electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.

BIEL

US$0.0002

7D

33.3%

1Y

33.3%

Genflow Biosciences

Market Cap: UK£3.7m

Operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium.

GENF

UK£0.0095

7D

-5.0%

1Y

-55.8%

SenesTech

Market Cap: US$4.9m

Engages in the development and commercialization of a technology for managing animal pest populations through fertility control.

SNES

US$2.81

7D

1.1%

1Y

-60.3%

Core One Labs

Market Cap: CA$6.8m

Operates as a psychedelic research and development company.

COOL

CA$0.14

7D

0%

1Y

-46.3%

Therma Bright

Market Cap: CA$6.8m

Acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace.

THRM

CA$0.015

7D

0%

1Y

0%

Innovative Holdings Alliance

Market Cap: US$4.9m

A medical technology holding company, offers personal care products in North America.

IHAI

US$0.093

7D

-13.5%

1Y

-7.0%

DATATRAK International

Market Cap: US$4.8m

A technology and services company, provides unified clinical solutions and related services for the clinical trials industry.

DTRK

US$0.23

7D

-25.0%

1Y

-52.4%

Autonomix Medical

Market Cap: US$4.8m

A development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system.

AMIX

US$1.95

7D

11.4%

1Y

-95.8%

Eastgate Biotech

Market Cap: US$4.8m

A development stage company, develops novel formulations of natural compounds and pharmaceutical products.

ETBI

US$0.0045

7D

0%

1Y

n/a

TrivarX

Market Cap: AU$7.4m

A health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States.

TRI

AU$0.012

7D

-7.7%

1Y

-60.0%

Epsilon Healthcare

Market Cap: AU$7.2m

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

EPN

AU$0.024

7D

0%

1Y

20.0%

Invion

Market Cap: AU$7.4m

A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.

IVX

AU$0.081

7D

-19.0%

1Y

-83.8%

Ecofibre

Market Cap: AU$7.3m

Engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia.

EOF

AU$0.02

7D

0%

1Y

-63.6%

Virax Biolabs Group

Market Cap: US$4.7m

A biotechnology company, distributes, markets, and sells diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.

VRAX

US$1.08

7D

0.9%

1Y

30.1%

dorsaVi

Market Cap: AU$7.3m

Engages in the development and sale of motion analysis technologies in Australia, Europe, and the United States.

DVL

AU$0.01

7D

11.1%

1Y

-28.6%

Conduit Pharmaceuticals

Market Cap: US$4.7m

A clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility.

CDT

US$0.39

7D

-4.7%

1Y

-99.9%

Sharps Technology

Market Cap: US$4.7m

A medical device and pharmaceutical packaging company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

STSS

US$4.57

7D

-1.9%

1Y

-99.7%

Zero Candida Technologies

Market Cap: CA$6.5m

A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis.

ZCT

CA$0.33

7D

-2.9%

1Y

n/a

Valeo Pharma

Market Cap: US$4.6m

A specialty pharmaceutical company, engages in the acquisition, in-licensing brands, and sale of pharmaceuticals and hospital specialty products for unmet medical needs in Canada.

VPHI.F

US$0.047

7D

0%

1Y

-59.4%

WEED

Market Cap: US$4.6m

Focuses on the development and application of cannabis-derived compounds for the treatment of human diseases and animal ailments in the United States and Australia.

BUDZ

US$0.034

7D

8.8%

1Y

-56.3%

Reflect Scientific

Market Cap: US$4.6m

Through its subsidiaries, engages in the design, development, and sale of scientific equipment for the life science and manufacturing industries worldwide.

RSCF

US$0.054

7D

34.5%

1Y

0.2%

Celadon Pharmaceuticals

Market Cap: UK£3.4m

Engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines.

CEL

UK£0.05

7D

0%

1Y

-94.6%

Affimed

Market Cap: US$4.6m

A clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.

AFMD

US$0.28

7D

-59.7%

1Y

-94.6%

T2 Biosystems

Market Cap: US$4.6m

An in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally.

TTOO

US$0.16

7D

12.2%

1Y

-97.3%

Alaunos Therapeutics

Market Cap: US$4.5m

A clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders.

TCRT

US$2.84

7D

-0.4%

1Y

-74.4%

Quoin Pharmaceuticals

Market Cap: US$4.5m

A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.

QNRX

US$7.70

7D

25.8%

1Y

-71.2%

PD-Rx Pharmaceuticals

Market Cap: US$4.5m

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.

PDRX

US$2.75

7D

0%

1Y

n/a

Bakhu Holdings

Market Cap: US$4.5m

Produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use.

BKUH

US$0.015

7D

0%

1Y

-87.7%

Xenetic Biosciences

Market Cap: US$4.5m

A biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers.

XBIO

US$2.91

7D

-6.1%

1Y

-22.8%

Invex Therapeutics

Market Cap: AU$7.0m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

IXC

AU$0.093

7D

-4.1%

1Y

22.4%

Page 42 of 65